HAENDLER; Bernard

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAENDLER; Bernard.The latest application filed is for "combination of ar antagonists and targeted thorium conjugates".

Company Profile

2.5.20

HAENDLER; Bernard - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Ar Antagonists And Targeted Thorium Conjugates App 20220118123 - HAMMER; Stefanie ; et al.	2022-04-21
Combination Of Atr Kinase Inhibitors With 2,3-dihydroimidazo[1,2-c]quinazoline Compounds App 20210369724 - WENGNER; Antje Margret ; et al.	2021-12-02
Combination of a PI3K-inhibitor with an androgen receptor antagonist Grant 11,185,549 - Haendler November 30, 2	2021-11-30
Combination Of A Pi3k-inhibitor With An Androgen Receptor Antagonist App 20200222414 - HAENDLER; Bernard	2020-07-16
Method For Stratification Of Melanoma Patients By Determination Of Oxygen Consumption, Ppargc1a, Ppargc1b And Mitf Levels App 20180164317 - HAENDLER; Bernard ; et al.	2018-06-14
2,3-benzodiazepines Grant 9,890,147 - Siegel , et al. February 13, 2	2018-02-13
BET protein-inhibiting 5-aryltriazoleazepines Grant 9,663,523 - Schmees , et al. May 30, 2	2017-05-30
Bet-protein Inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones With Meta-substituted Aromatic Amino- Or Ether Groups App 20170121322 - SCHMEES; Norbert ; et al.	2017-05-04
Substituted Dihydropyrido[3,4-b]pyrazinones As Dual Inhibitors Of Bet Proteins And Polo-like Kinases App 20160272635 - Schmees; Norbert ; et al.	2016-09-22
Bet-protein-inhibiting Dihydropyridopyrazinones App 20160193206 - SCHMEES; Norbert ; et al.	2016-07-07
Modified Bet-protein-inhibiting Dihydroquinoxalinones And Dihydropyridopyrazinones App 20160176867 - SCHMEES; Norbert ; et al.	2016-06-23
Bicyclo 2,3-benzodiazepines And Spirocyclically Substituted 2,3-benzodiazepines App 20160129011 - SIEGEL; Stephan ; et al.	2016-05-12
Pyrrolo- And Pyrazolo-triazolodiazepines As Bet-protein Inhibitors For Treating Hyperproliferative Diseases App 20160009725 - SCHMEES; Norbert ; et al.	2016-01-14
4-substituted Pyrrolo- And Pyrazolo-diazepines App 20150376196 - SCHMEES; Norbert ; et al.	2015-12-31
Bet-protein-inhibiting Dihydroxyquinoxalinones App 20150344444 - SCHMEES; Norbert ; et al.	2015-12-03
Bet Protein-inhibiting 5-aryl Triazole Azepines App 20150299201 - Schmees; Norbert ; et al.	2015-10-22
2,3-benzodiazepines App 20150203483 - Siegel; Stephan ; et al.	2015-07-23
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines App 20140213575 - Schmees; Norbert ; et al.	2014-07-31
Substituted (Heteroarylmethyl)thiohydantoins App 20120251551 - Lucking; Ulrich ; et al.	2012-10-04
Human PEM as a target for birth control and treatment of Alzheimer's disease Grant 6,825,329 - Weiss , et al. November 30, 2	2004-11-30
Method for in vitro diagnosis of endometriosis Grant 6,780,594 - Hess-Stumpp , et al. August 24, 2	2004-08-24
Method for in vitro diagnosis of endometriosis App 20030077589 - Hess-Stumpp, Holger ; et al.	2003-04-24
Human androgen receptor variants App 20020165381 - Ahrens-Fath, Isabelle ; et al.	2002-11-07
Human PEM as a target for birth contol and treatment of Alzheimer's disease App 20020048764 - Weiss, Bertram ; et al.	2002-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.